Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

被引：0
|
作者：
Jaime Gómez-Millán
Maria Dolores Toledo
Yolanda Lupiañez
Antonio Rueda
Jose Manuel Trigo
Antonio Sachetti
Jose Antonio Medina
机构：
[1] Hospital Clinico Universitario Virgen de la Victoria,Radiation Oncology Department
[2] Hospital Costa del Sol Marbella,Medical Oncology Department
[3] Hospital Clinico Universitario Virgen de la Victoria,Medical Oncology Department
[4] Radiation Oncology Department Centro radio-oncológico andaluz (CROASA),undefined
来源：
Clinical and Translational Oncology | 2013年 / 15卷
关键词：
Head and neck cancer; Late toxicity; Accelerated radiation; Concomitant boost radiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 326
页数：5
相关论文
共 50 条
  • [41] Competing causes of death in the head and neck cancer population
    Massa, Sean T.
    Osazuwa-Peters, Nosayaba
    Christopher, Kara M.
    Arnold, Lauren D.
    Schootman, Mario
    Walker, Ronald J.
    Varvares, Mark A.
    ORAL ONCOLOGY, 2017, 65 : 8 - 15
  • [42] The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer
    Vokes, EE
    Haraf, DJ
    Kies, MS
    SEMINARS IN ONCOLOGY, 2000, 27 (04) : 34 - 38
  • [43] A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer
    Lee, Ji Yun
    Sun, Jong-Mu
    Oh, Dongryul
    Lim, Sung Hee
    Chi, Sangah
    Lee, Se-Hoon
    Jung, Sin-Ho
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Park, Keunchil
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 217 - 223
  • [44] Concurrent cisplatin and radiotherapy in advanced head and neck cancer
    Rehan Asif
    Kamlesh Chandra
    Vanita Chopra
    M. L. B. Bhatt
    Indian Journal of Otolaryngology and Head and Neck Surgery, 2003, 55 (2): : 94 - 96
  • [45] A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer
    Gupta, Parul
    Dhull, Anil Kumar
    Kaushal, Vivek
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (03) : 478 - 484
  • [46] Dose density of weekly cisplatin delivered concurrent with radiotherapy in head and neck cancer patients
    Laidley, H.
    Noble, D.
    Barnett, G.
    Benson, R.
    Jefferies, S.
    Gemill, J.
    Burnet, N.
    CLINICAL ONCOLOGY, 2017, 29 : S6 - S7
  • [47] Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab
    Koutcher, Lawrence D.
    Wolden, Suzanne
    Lee, Nancy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 472 - 476
  • [48] Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
    Wee, Chan Woo
    Keam, Bhumsuk
    Heo, Dae Seog
    Sung, Myung-Whun
    Won, Tae-Bin
    Wu, Hong-Gyun
    RADIATION ONCOLOGY JOURNAL, 2015, 33 (02): : 98 - 108
  • [49] Simultaneous radiochemotherapy versus concomitant boost radiation for advanced inoperable head and neck cancer
    Schäfer, U
    Schüller, P
    Micke, O
    Willich, N
    ACTA ONCOLOGICA, 2000, 39 (04) : 523 - 528
  • [50] Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study)
    Mir, Nabiel Ali
    Juloori, Aditya
    Swiecicki, Paul
    Katipally, Rohan Reddy
    Agrawal, Nishant
    Blair, Elizabeth A.
    Haraf, Daniel J.
    Pearson, Alexander T.
    Vokes, Everett E.
    Rosenberg, Ari Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345